The US Food and Drug Administration (FDA) ordered the Johnson & Johnson company to discard 60 million doses of its anti-COVID vaccine that were produced during the incident at a factory in the US city of Baltimore, where a part of the drugs was contaminated.
It was reported earlier that at an Emergent BioSolutions company factory in Baltimore the ingredients of two different coronavirus vaccines were confused, and that 15 million doses of Johnson & Johnson’s vaccine were spoiled as a result.
- Neuroscience Breakthrough: Study Pinpoints Brain Activity That Helps Prevent Us From Getting Lost
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
“Federal regulators told Johnson & Johnson that around 60 million doses of its coronavirus vaccine produced in the troubled Baltimore factory cannot be used due to possible contamination,” according to the sources.
The US medical regulator plans to authorize the use of some 10 million doses of this vaccine both domestically and for export while stressing that it cannot guarantee that those doses have not been contaminated.
The possibility of reopening the plant in Baltimore is still pending.
In contrast to the other corona vaccines approved to date, the Johnson & Johnson vaccine only requires one injection syringe for comprehensive protection.
In addition, storage and delivery are comparatively easy. The J&J vaccine was therefore increasingly used in the USA and is also intended to help accelerate vaccination campaigns in the EU.
Photo by Matthias Bein/picture alliance via Getty Images